IOBCF:OTCMKTS
Ion Beam Applications SA
17,95Â US$
arrow_upward
+8,43%(+1,40) 1 d
21 apr., 16:00:00 GMTâ4 · USD
search
Alla symboler
1 d
5 d
1 m
6 m
Hittills i Ă„r
1 Ă„r
5 Ă„r
MAX
| Symbol | Pris | Ăndring | Ăndring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för IOBCF âŠ
Ăppen
16,90Â US$
Högt
17,95Â US$
LĂ„gt
16,90Â US$
BörsvÀrde
436,06Â mn
Genomsn. vol.
238,00
Volym
270,00
52v högst
19,00Â US$
52v lÀgst
11,11Â US$
Beta
1,18
UtestÄende aktier
30,28Â mn
Antal anstÀllda
2Â tn
Nyheter och artiklar
FrÄn kÀllor pÄ webben
MarketBeat
·
för 10 minuter sedan
Cellectis (NASDAQ:CLLS) Shares Pass Below 200-Day Moving Average - Time to Sell?
XTB.com
·
för 57 minuter sedan
Chart of the Day đ S&P 500 extends gains, supported by CTA fund buying
Investing.com
·
för 4 timmar sedan
Yesway prices IPO at $20 per share, to list on Nasdaq
Investor's Business Daily
·
för 13 timmar sedan
Dow Jones AI Giant Nvidia, Sterling, Viking In Or Near Buy Zones
Profil
IBA is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain and became a university spin-off. It employs about 1500 people in 40 locations. The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation.
IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001, and for University of Pennsylvania's Proton Center in 2009.
It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom.
In 2017, IBA invested âŹ16 million in the construction of a new logistics and production center in Louvain-la-Neuve. Wikipedia
Om Ion Beam Applications SA
AI-innehÄll kan innehÄlla fel. LÀs mer